DRIO - DarioHealth Corp Stock Price, Fair Value and News

$12.46+0.57 (+4.79%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DRIO Price Action

Last 7 days

4.1%

Last 30 days

-9.3%

Last 90 days

21.9%

Trailing 12 Months

-16.9%

DRIO RSI Chart

DRIO Valuation

Market Cap

84.3M

Price/Earnings (Trailing)

-1.99

Price/Sales (Trailing)

3.41

EV/EBITDA

-2.19

Price/Free Cashflow

-3.13

DRIO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DRIO Fundamentals

DRIO Revenue

Revenue (TTM)

24.7M

Rev. Growth (Yr)

-32.55%

Rev. Growth (Qtr)

-6.74%

DRIO Earnings

Earnings (TTM)

-42.3M

Earnings Growth (Yr)

15.12%

Earnings Growth (Qtr)

19.43%

DRIO Profitability

Operating Margin

89.02%

EBT Margin

-170.38%

Return on Equity

-56.47%

Return on Assets

-35.94%

Free Cashflow Yield

-31.93%

DRIO Investor Care

Shares Dilution (1Y)

297.00%

Diluted EPS (TTM)

11.06

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	28.0M	27.1M	24.7M	0
2024	19.0M	19.1M	23.1M	27.0M
2023	26.7M	26.6M	23.5M	20.4M
2022	25.0M	25.9M	26.9M	27.7M
2021	9.5M	13.0M	16.6M	20.5M
2020	7.0M	7.1M	7.3M	7.6M
2019	7.9M	7.5M	7.5M	7.6M
2018	5.9M	6.8M	7.3M	7.4M
2017	3.2M	3.8M	4.4M	5.2M
2016	1.3M	1.8M	2.3M	2.8M
2015	244.0K	437.0K	630.0K	823.0K
2014	0	0	0	51.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About DarioHealth Corp

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its user-centric multi-chronic condition digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move to address most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

CEO	Mr. Erez Raphael
WEBSITE	dariohealth.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	241

DarioHealth Corp Frequently Asked Questions

What is the ticker symbol for DarioHealth Corp? What does DRIO stand for in stocks?

DRIO is the stock ticker symbol of DarioHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DarioHealth Corp (DRIO)?

As of Wed Dec 03 2025, market cap of DarioHealth Corp is 84.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DRIO stock?

You can check DRIO's fair value in chart for subscribers.

Is DarioHealth Corp a good stock to buy?

The fair value guage provides a quick view whether DRIO is over valued or under valued. Whether DarioHealth Corp is cheap or expensive depends on the assumptions which impact DarioHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DRIO.

What is DarioHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, DRIO's PE ratio (Price to Earnings) is -1.99 and Price to Sales (PS) ratio is 3.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DRIO PE ratio will change depending on the future growth rate expectations of investors.